c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18

Biochemical Journal

Volumn 430, Issue 2, 2010, Pages 345-354

  Yeap, Yvonne Y C ^a   Ng, Ivan H W ^a   Badrian, Bahareh ^b   Nguyen, Tuong Vi ^a,d   Yip, Yan Y ^a   Dhillon, Amardeep S ^a   Mutsaers, Steven E ^b   Silke, John ^c   Bogoyevitch, Marie A ^a   Ng, Dominic C H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Activator protein 1 (AP 1); c Jun; c Jun N terminal kinase (JNK); Proliferation; Stathmin

Indexed keywords

CELL CULTURE; CELL DEATH; FIBROBLASTS; PHOSPHORYLATION; PHYSIOLOGY; RNA; TISSUE; TRANSCRIPTION FACTORS;

ACTIVATOR PROTEIN-1; C-JUN; C-JUN N-TERMINAL KINASE; PROLIFERATION; STATHMIN;

CELL PROLIFERATION;

CELL PROTEIN; CYTOSOLIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; ONCOPROTEIN 18; PROTEIN C JUN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STATHMIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE 9;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATTENUATION; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; MICROTUBULE; MITOSIS SPINDLE; MOLECULAR DYNAMICS; MUTANT; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHOSPHORYLATION;

MURINAE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; STATHMIN;

EID: 77956702706     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20100425     Document Type: Article

References (48)

1. Bogoyevitch, M. A. (2006) The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting. BioEssays 28, 923-934
2. Karin, M. and Gallagher, E. (2005) From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283-295 (Pubitemid 40904256)
3. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J. and Flavell, R. A. (1998) Defective T cell differentiation in the absence of Jnk1. Science 282, 2092-2095
4. Huang, C., Jacobson, K. and Schaller, M. D. (2004) MAP kinases and cell migration. J. Cell Sci. 117, 4619-4628
5. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A. and Davis, R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874
6. Kennedy, N. J. and Davis, R. J. (2003) Role of JNK in tumor development. Cell Cycle 2, 199-201
7. Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar-Sagi, D., Flavell, R. A. and Davis, R. J. (2003) Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17, 629-637 (Pubitemid 36307547)
8. 2-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 62, 1343-1348
9. Tong, C., Yin, Z., Song, Z., Dockendorff, A., Huang, C., Mariadason, J., Flavell, R. A., Davis, R. J., Augenlicht, L. H. and Yang, W. (2007) c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am. J. Pathol. 171, 297-303
10. Tsuiki, H., Tnani, M., Okamoto, I., Kenyon, L. C., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T. and Wong, A. J. (2003) Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 63, 250-255
11. 2-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin. Cancer Res. 9, 391-401
12. Behrens, A., Jochum, W., Sibilia, M. and Wagner, E. F. (2000) Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657-2663
13. Behrens, A., Sibilia, M. and Wagner, E. F. (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21, 326-329
14. 2-terminal kinase-2-deficient mice. Cancer Res. 61, 3908-3912
15. Jaeschke, A., Karasarides, M., Ventura, J. J., Ehrhardt, A., Zhang, C., Flavell, R. A., Shokat, K. M. and Davis, R. J. (2006) JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 23, 899-911
16. Sabapathy, K., Hochedlinger, K., Nam, S. Y., Bauer, A., Karin, M. and Wagner, E. F. (2004) Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713-725
17. Vogt, P. K. (2001) Jun, the oncoprotein. Oncogene 20, 2365-2377
18. Shaulian, E. and Karin, M. (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400
19. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P. and Wagner, E. F. (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619
20. Taylor, W. R. and Stark, G. R. (2001) Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815
21. Cassimeris, L. (2002) The oncoprotein 18/stathmin family of microtubule destabilizers. Curr. Opin. Cell Biol. 14, 18-24
22. Rubin, C. I. and Atweh, G. F. (2004) The role of stathmin in the regulation of the cell cycle. J. Cell. Biochem. 93, 242-250
23. Iancu, C., Mistry, S. J., Arkin, S., Wallenstein, S. and Atweh, G. F. (2001) Effects of stathmin inhibition on the mitotic spindle. J. Cell Sci. 114, 909-916
24. Marklund, U., Larsson, N., Gradin, H. M., Brattsand, G. and Gullberg, M. (1996) Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J. 15, 5290-5298 (Pubitemid 26336212)
25. Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Gonthier, M. P., Sobel, A., Lidereau, R. and Bieche, I. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82, 142-150
26. Hasegawa, A., Hisatomi, O., Yamamoto, S., Ono, E. and Tokunaga, F. (2007) Stathmin expression during newt retina regeneration. Exp. Eye Res. 85, 518-527
27. Mistry, S. J. and Atweh, G. F. (1999) Stathmin expression in immortalized and oncogene transformed cells. Anticancer Res. 19, 573-577
28. Sadow, P. M., Rumilla, K. M., Erickson, L. A. and Lloyd, R. V. (2008) Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr. Pathol. 19, 97-103
29. Alli, E., Yang, J. M. and Hait, W. N. (2007) Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26, 1003-1012
30. Mistry, S. J., Bank, A. and Atweh, G. F. (2005) Targeting stathmin in prostate cancer. Mol. Cancer Ther. 4, 1821-1829
31. Larsson, N., Melander, H., Marklund, U., Osterman, O. and Gullberg, M. (1995) G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J. Biol. Chem. 270, 14175-14183
32. Fang, L., Min, L., Lin, Y., Ping, G., Rui, W., Ying, Z., Xi, W., Ting, H., Li, L., Ke, D. et al. (2010) Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549. Cell Signalling 22, 166-173
33. 2/M cell-cycle arrest. Int. J. Cancer 88, 685-691
34. Polzin, R. G., Benlhabib, H., Trepel, J. and Herrera, J. E. (2004) E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Gene 341, 209-218
35. Kinoshita, I., Leaner, V., Katabami, M., Manzano, R. G., Dent, P., Sabichi, A. and Birrer, M. J. (2003) Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth. Oncogene 22, 2710-2722
36. Tararuk, T., Ostman, N., Li, W., Bjorkblom, B., Padzik, A., Zdrojewska, J., Hongisto, V., Herdegen, T., Konopka, W., Courtney, M. J. and Coffey, E. T. (2006) JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J. Cell Biol. 173, 265-277
37. Vince, J. E., Wong, W. W., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M. et al. (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682-693
38. Ng, D. C., Lin, B. H., Lim, C. P., Huang, G., Zhang, T., Poli, V. and Cao, X. (2006) Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J. Cell Biol. 172, 245-257 (Pubitemid 43112971)
39. Balogh, A., Mege, R. M. and Sobel, A. (1996) Growth and cell density-dependent expression of stathmin in C2 myoblasts in culture. Exp. Cell Res. 224, 8-15
40. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23, 2871-2882
41. Leventaki, V., Drakos, E., Medeiros, L. J., Lim, M. S., Elenitoba-Johnson, K. S., Claret, F. X. and Rassidakis, G. Z. (2007) NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood 110, 1621-1630
42. Lamph, W. W., Wamsley, P., Sassone-Corsi, P. and Verma, I. M. (1988) Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334, 629-631
43. Llense, F. and Martin-Blanco, E. (2008) JNK signaling controls border cell cluster integrity and collective cell migration. Curr. Biol. 18, 538-544
44. Wei, Y., Pattingre, S., Sinha, S., Bassik, M. and Levine, B. (2008) JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678-688
45. Das, M., Jiang, F., Sluss, H. K., Zhang, C., Shokat, K. M., Flavell, R. A. and Davis, R. J. (2007) Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl. Acad. Sci. U.S.A. 104, 15759-15764
46. Bode, A. M. and Dong, Z. (2007) The functional contrariety of JNK. Mol. Carcinog. 46, 591-598
47. Mechta-Grigoriou, F., Gerald, D. and Yaniv, M. (2001) The mammalian Jun proteins: redundancy and specificity. Oncogene 20, 2378-2389 (Pubitemid 32531296)
48. Wong, Q. W., Lung, R. W., Law, P. T., Lai, P. B., Chan, K. Y., To, K. F. and Wong, N. (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135, 257-269